Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain
Clinical trial NCT02455999 · COMPLETED
Trial details
- NCT number
- NCT02455999
- Sponsor
- Sylentis, S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.